查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲基因测序市场：按产品、最终用户和国家进行的分析和预测（2024-2033 年）
市场调查报告书
商品编码
1637364

欧洲基因测序市场：按产品、最终用户和国家进行的分析和预测（2024-2033 年）

Europe Genome Sequencing Market: Focus on Product, End User, and Country - Analysis and Forecast: 2024-2033
出版日期: | 出版商: BIS Research | 英文 67 Pages | 商品交期: 1-5个工作天内

价格

欧洲基因测序市场预计将从 2024 年的 22.2 亿美元成长到 2033 年的 72.3 亿美元，预测期内的复合年增长率为 14.04%。

基因测序是确定生物体 DNA 完整序列的过程，使科学家能够破解其整个基因组成。该过程有助于识别基因变异及其对健康和疾病的潜在影响。欧洲基因测序市场正在不断扩大，原因包括定序成本下降、基因组检测的普及以及对使用次世代定序技术的产前和新生儿筛检计画的需求不断增长等因素。

长读定定序的应用日益广泛，它为复杂的遗传讯息提供了更详细和准确的洞察，进一步推动了市场的成长。此外，欧洲各地政府对基因测序计划的投资和倡议正在大幅提高基因组定序的可近性和采用率。

主要市场统计数据
预测期 2024-2033
2024 年评估 22.2亿美元
2033 年预测 72.3亿美元
复合年增长率 14.04％

随着人们对医疗保健的日益关注和精准医疗的发展，基因测序正在成为改善诊断、个人化治疗和疾病预防的重要工具。这些趋势预计将塑造欧洲基因测序市场的未来，确保持续的技术创新和更广泛的消费者使用机会。

基因检测需求的不断增长、精准医疗的应用日益广泛以及定序技术的不断进步是推动欧洲基因测序市场显着增长的因素之一。基因测序，也就是对生物体整个 DNA 序列的确定，正在成为研究、诊断和个人化医疗中越来越重要的工具。

市场区隔

细分一：按产品

  • 套件
  • 装置
  • 软体

细分 2：按最终用户

  • 製药和生物技术公司
  • 医院和诊断实验室
  • 大规模定序组织
  • 研究和学术机构
  • 其他的

细分 3：按地区

  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 义大利
    • 法国
    • 其他的

本报告研究了欧洲基因测序市场，并提供了关键趋势、市场影响因素分析、法律制度、技术发展和专利趋势、市场规模趋势和预测以及各细分市场和主要国家的详细资讯。竞争格局以及主要企业简介。

目录

执行摘要

范围和定义

第 1 章欧洲基因测序市场：产业分析

  • 主要趋势：当前和未来的影响评估
    • 将人工智慧和机器学习融入基因测序定序
    • 主要企业之间的伙伴关係、联盟和扩张日益增多
  • 监管分析
  • 价值和供应链分析

2. 欧洲基因测序市场：未来展望

  • 专利分析
    • 专利分析（按年份）
    • 专利分析（按国家）
  • 竞争性基准化分析
    • 市场占有率
    • 品牌知名度
  • 临床实施顺序
  • 未来展望

第三章基因测序市场（按地区）

  • 区域概况
  • 推动要素与限制因素
  • 欧洲
    • 区域概况
    • 市场成长推动要素
    • 市场问题
    • 按产品
    • 按最终用户
    • 德国
    • 英国
    • 西班牙
    • 义大利
    • 法国
    • 其他的

第 4 章基因测序市场：竞争基准化分析与公司简介

  • 关键策略和发展
    • 伙伴关係、合作和业务扩展
    • 法律法规
    • 新服务
    • M&A
    • 资金筹措活动
  • 公司简介
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd.
    • OncoDNA
    • Oxford Nanopore Technologies plc
    • QIAGEN NV

第五章调查方法

Product Code: BHP2487SS

Introduction to Europe Genome Sequencing Market

The Europe genome sequencing market was valued at $2.22 billion in 2024 and is expected to reach $7.23 billion by 2033, growing at a CAGR of 14.04% between 2024 and 2033. Through the process of identifying the entire sequence of an organism's DNA, genome sequencing allows scientists to decipher its entire genetic composition. This process helps identify genetic variations and their potential impact on health and disease. The genome sequencing market in Europe is expanding due to factors such as the decreasing cost of sequencing, increasing adoption of genome testing, and the growing demand for prenatal and newborn screening programs that leverage next-generation sequencing technologies.

The expanding applications of long-read sequencing, which provide more detailed and accurate insights into complex genetic information, further drive market growth. In addition, government investments and initiatives in genome sequencing projects across Europe have significantly boosted accessibility and adoption.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$2.22 Billion
2033 Forecast$7.23 Billion
CAGR14.04%

As the area keeps its attention on developments in healthcare and precision medicine, genome sequencing is becoming a critical tool for improving diagnostics, personalized treatments, and disease prevention. These trends are set to shape the future of the genome sequencing market in Europe, ensuring continued innovation and wider consumer access.

Market Introduction

The growing demand for genetic testing, the growing use of precision medicine, and improvements in sequencing technologies are all contributing to the notable growth of the European genome sequencing market. An increasingly important tool in research, diagnostics, and individualized healthcare is genome sequencing, which decodes an organism's entire DNA sequence.

As next-generation sequencing (NGS) becomes more widely available and sequencing costs decline, the technology becomes more accessible, facilitating its integration into European healthcare systems. Prenatal and neonatal screening, cancer diagnosis, rare disease detection, and pharmacogenomics are important uses.

The market is being further stimulated by government programs and investments in genomic research projects, such as the UK's 100,000 Genomes Project. More precise and thorough genetic analysis is now possible thanks to the growing use of long-read sequencing technologies, improving clinical outcomes.

As Europe continues to prioritize innovation in healthcare, the genome sequencing market is set to play a pivotal role in advancing medical research and delivering personalized treatments.

Market Segmentation

Segmentation 1: by Product

  • Kits
  • Instruments
  • Software

Segmentation 2: by End User

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostic Laboratories
  • Population Sequencing Organizations
  • Research and Academic Institutes
  • Others

Segmentation 3: by Region

  • Europe
    • Germany
    • U.K.
    • Spain
    • Italy
    • France
    • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe genome sequencing market has been segmented based on various categories, such as by product, end user, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe genome sequencing market is a highly fragmented market, with many public and few private companies. Key players in the genome sequencing market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Eurofins Scientific S.E.
  • F. Hoffmann-La Roche Ltd.
  • OncoDNA
  • Oxford Nanopore Technologies plc
  • QIAGEN N.V.

Table of Contents

Executive Summary

Scope and Definition

1 Europe Genome Sequencing Market: Industry Analysis

  • 1.1 Key Trends: Current and Future Impact Assessment
    • 1.1.1 Integration of Artificial Intelligence and Machine Learning in Genome Sequencing
    • 1.1.2 Increasing Partnerships, Alliances, and Business Expansions among Key Players
  • 1.2 Regulatory Analysis
  • 1.3 Value and Supply Chain Analysis

2 Europe Genome Sequencing Market: Future Outlook

  • 2.1 Patent Analysis
    • 2.1.1 Patent Analysis (by Year)
    • 2.1.2 Patent Analysis (by Country)
  • 2.2 Competitive Benchmarking
    • 2.2.1 Market Share
    • 2.2.2 Brand Recognition
  • 2.3 Sequencing Clinical Adoption
  • 2.4 Future Outlook

3 Genome Sequencing Market (By Region)

  • 3.1 Regional Summary
  • 3.2 Drivers and Restraints
  • 3.3 Europe
    • 3.3.1 Regional Overview
    • 3.3.2 Driving Factors for Market Growth
    • 3.3.3 Factors Challenging the Market
    • 3.3.4 By Product
    • 3.3.5 By End User
    • 3.3.6 Germany
      • 3.3.6.1 By Product
    • 3.3.7 U.K.
      • 3.3.7.1 By Product
    • 3.3.8 Spain
      • 3.3.8.1 By Product
    • 3.3.9 Italy
      • 3.3.9.1 By Product
    • 3.3.10 France
      • 3.3.10.1 By Product
    • 3.3.11 Rest-of-Europe
      • 3.3.11.1 By Product

4 Genome Sequencing Market - Competitive Benchmarking and Company Profiles

  • 4.1 Key Strategies and Development
    • 4.1.1 Partnerships, Alliances, and Business Expansions
    • 4.1.2 Regulatory and Legal Activities
    • 4.1.3 New Offerings
    • 4.1.4 Mergers and Acquisitions
    • 4.1.5 Funding Activities
  • 4.2 Company Profiles
    • 4.2.1 Eurofins Scientific S.E.
      • 4.2.1.1 Overview
      • 4.2.1.2 Top Products and Services
      • 4.2.1.3 Top Competitors
      • 4.2.1.4 Key Personnel
      • 4.2.1.5 Analyst View
    • 4.2.2 F. Hoffmann-La Roche Ltd.
      • 4.2.2.1 Overview
      • 4.2.2.2 Top Products and Services
      • 4.2.2.3 Top Competitors
      • 4.2.2.4 Key Personnel
      • 4.2.2.5 Analyst View
    • 4.2.3 OncoDNA
      • 4.2.3.1 Overview
      • 4.2.3.2 Top Products and Services
      • 4.2.3.3 Top Competitors
      • 4.2.3.4 Key Personnel
      • 4.2.3.5 Analyst View
    • 4.2.4 Oxford Nanopore Technologies plc
      • 4.2.4.1 Overview
      • 4.2.4.2 Top Products and Services
      • 4.2.4.3 Top Competitors
      • 4.2.4.4 Key Personnel
      • 4.2.4.5 Analyst View
    • 4.2.5 QIAGEN N.V.
      • 4.2.5.1 Overview
      • 4.2.5.2 Top Products and Services
      • 4.2.5.3 Top Competitors
      • 4.2.5.4 Key Personnel
      • 4.2.5.5 Analyst View

5 Research Methodology

  • 5.1 Data Sources
    • 5.1.1 Primary Data Sources
    • 5.1.2 Secondary Data Sources
    • 5.1.3 Data Triangulation

List of Figures

  • Figure 1: Europe Genome Sequencing Market, $Billion, 2024, 2028, and 2033
  • Figure 2: Genome Sequencing Market (by Region), $Billion, 2023, 2027, and 2033
  • Figure 3: Europe Genome Sequencing Market (by End User), $Billion, 2023, 2027, and 2033
  • Figure 4: Europe Genome Sequencing Market (by Product), $Billion, 2023, 2027, and 2033
  • Figure 5: Key Players' Strategic Priorities
  • Figure 6: Potential Future Directions
  • Figure 7: Companies Utilizing Artificial Intelligence in Genomics
  • Figure 8: Share of Partnerships, Alliances, and Business Expansions vs Other Strategies
  • Figure 9: Some of the Key Partnerships, Alliances, and Business Expansions and their Impact on the Sequencing Market
  • Figure 10: Value and Supply Chain Analysis, Genome Sequencing Market
  • Figure 11: Genome Sequencing Market, Patent Analysis (by Year), January 2021-December 2023
  • Figure 12: Genome Sequencing Market, Patent Analysis (by Country), January 2021-December 2023
  • Figure 13: Europe Genome Sequencing Market, Market Share, 2023
  • Figure 14: Clinical Utility of Genome Sequencing
  • Figure 15: Future Outlook for Genome Sequencing
  • Figure 16: Germany Genome Sequencing Market, $Billion, 2023-2033
  • Figure 17: U.K. Genome Sequencing Market, $Billion, 2023-2033
  • Figure 18: Spain Genome Sequencing Market, $Billion, 2022-2023
  • Figure 19: Italy Genome Sequencing Market, $Billion, 2023-2033
  • Figure 20: France Genome Sequencing Market, $Billion, 2023-2033
  • Figure 21: Partnerships, Alliances, and Business Expansions Activities, January 2020-April 2024
  • Figure 22: Regulatory and Legal Activities, January 2020-April 2024
  • Figure 23: New Offerings, January 2020-April 2024
  • Figure 24: Mergers and Acquisitions, January 2020-April 2024
  • Figure 25: Funding Activities, January 2020-April 2024
  • Figure 26: Data Triangulation
  • Figure 27: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Genome Sequencing Market, Market Opportunities
  • Table 3: Current and Future Impact of Trends
  • Table 4: Regulatory Landscape (by Country)
  • Table 5: Comparison of Some of the Key Sequencers
  • Table 6: Genome Sequencing Market (by Region), $Billion, 2023-2033
  • Table 7: Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 8: Canada Genome Sequencing Market (by End User), $Billion, 2023-2033
  • Table 9: Germany Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 10: U.K. Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 11: Spain Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 12: Italy Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 13: France Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 14: Rest-of-Europe Genome Sequencing Market, $Billion, 2023-2033
  • Table 15: Rest-of-Europe Genome Sequencing Market (by Product), $Billion, 2023-2033
  • Table 16: Europe Genome Sequencing Market, Key Development Analysis, January 2020-April 2024